Effects Of Walnut-Enriched Diet On Blood Lipids And Glucose Profiles In Hyperlipidemic Subjects
Primary Purpose
Hyperlipidemias
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Walnut-enriched Group
Sponsored by
About this trial
This is an interventional treatment trial for Hyperlipidemias focused on measuring Serum lipids, Hyperlipidemia, Walnut
Eligibility Criteria
Inclusion Criteria:
- Hyperlipidemic patients who are not using any lipid lowering medications
- Non-smoker
- No alcohol consumption
- Individuals who are having ≤30kg/m2
- Individuals who do not have any allergy for nut consumption
- Female participants who are not pregnant or breastfeeding
- Individuals should not be in a weight loss programme
- Having not consumed regular nuts for the last 1 month,
- Except hypertension, they should not have other chronic diseases (such as diabetes, chronic renal failure)
- No intense exercise
Exclusion Criteria:
- Failure to meet the criteria for inclusion criteria.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Control Group
Interventional Group
Arm Description
In 'Control group' participants had 6 week follow-up without any intervention.
In 'Interventional group' participants had 6 week follow-up and during that period of time, they were asked to consume 40g/day walnut. Participants in intervention group was ensured to consume all 40g of walnut every day, during their snack times for 6 weeks.
Outcomes
Primary Outcome Measures
Reduction in serum lipids and fasting glucose levels
In both group, participants have decreased serum total cholesterol and LDL-cholesterol.However especially walnut-enrcihed group significantly changed fasting glucose and insulin levels.
Secondary Outcome Measures
Full Information
NCT ID
NCT03680027
First Posted
September 19, 2018
Last Updated
September 21, 2018
Sponsor
Eastern Mediterranean University
1. Study Identification
Unique Protocol Identification Number
NCT03680027
Brief Title
Effects Of Walnut-Enriched Diet On Blood Lipids And Glucose Profiles In Hyperlipidemic Subjects
Official Title
Effects Of Walnut-Enriched Diet On Blood Lipids And Glucose Profiles In Hyperlipidemic Subjects: A Randomized-Controlled Trial: A Randomized-Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
September 2018
Overall Recruitment Status
Completed
Study Start Date
July 10, 2015 (Actual)
Primary Completion Date
August 27, 2015 (Actual)
Study Completion Date
September 30, 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Eastern Mediterranean University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Walnuts have been shown to reduce serum lipids in hyperlipidemic individuals with a well-controlled feeding trials. Current study have been determined the effects of daily walnut consumption on serum lipids, fasting glucose and insulin levels in hyperlipidemic individuals.
Detailed Description
In this, randomized controlled trial, mild to moderate hyperlipidemic subjects were randomly divided into 2 groups as walnut-enriched (n=20) and control (n=17) groups for 6 weeks. All subjects adhered to a medical nutrition therapy as low-fat and low-cholesterol diet. The walnut-enriched group was supplemented with 40 g/day of walnuts added to their diets. In order to follow nutritional status of subjects, they were visited every 15 days (in total 4 times). Anthropometric measurements of the subjects were taken and were monitored at each visit during the study. Blood samples were measured at the beginning and again at the end of the study.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hyperlipidemias
Keywords
Serum lipids, Hyperlipidemia, Walnut
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
37 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Control Group
Arm Type
No Intervention
Arm Description
In 'Control group' participants had 6 week follow-up without any intervention.
Arm Title
Interventional Group
Arm Type
Experimental
Arm Description
In 'Interventional group' participants had 6 week follow-up and during that period of time, they were asked to consume 40g/day walnut. Participants in intervention group was ensured to consume all 40g of walnut every day, during their snack times for 6 weeks.
Intervention Type
Dietary Supplement
Intervention Name(s)
Walnut-enriched Group
Intervention Description
All subjects supplemented with 40 g/day of walnuts for 6 weeks.
Primary Outcome Measure Information:
Title
Reduction in serum lipids and fasting glucose levels
Description
In both group, participants have decreased serum total cholesterol and LDL-cholesterol.However especially walnut-enrcihed group significantly changed fasting glucose and insulin levels.
Time Frame
Six weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Hyperlipidemic patients who are not using any lipid lowering medications
Non-smoker
No alcohol consumption
Individuals who are having ≤30kg/m2
Individuals who do not have any allergy for nut consumption
Female participants who are not pregnant or breastfeeding
Individuals should not be in a weight loss programme
Having not consumed regular nuts for the last 1 month,
Except hypertension, they should not have other chronic diseases (such as diabetes, chronic renal failure)
No intense exercise
Exclusion Criteria:
Failure to meet the criteria for inclusion criteria.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gözde Okburan
Organizational Affiliation
Eastern Mediterranean University
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Effects Of Walnut-Enriched Diet On Blood Lipids And Glucose Profiles In Hyperlipidemic Subjects
We'll reach out to this number within 24 hrs